Acquiring Company
Sanofi
Acquired Company
Dynavax Technologies
EmeryvilleBiotechnologyHealth CareMedicalPharmaceuticalBiotechnologyHealth CareTherapeuticsBiopharmaDescription
Sanofi has completed its acquisition of Dynavax Technologies. This acquisition is aimed at enhancing Sanofi's vaccine development and immunotherapy capabilities. The deal aligns with Sanofi's strategic focus on expanding its portfolio in the biopharmaceutical sector. The integration is expected to drive future growth and innovation.
Quick answer
Sanofi is acquiring Dynavax Technologies, announced April 23, 2026.
- How much did Sanofi pay for Dynavax Technologies?
- The deal value was not disclosed.
- What does Sanofi do?
- LONDON--(BUSINESS WIRE)--Gyroscope Therapeutics Holdings plc (Gyroscope), a clinical-stage gene therapy company focused on diseases of the eye, today announced that Sanofi, a global biopharmaceutical company, has..
- Where are Sanofi and Dynavax Technologies based?
- Dynavax Technologies is based in Emeryville, California, United States.
- Who are the decision-makers at Sanofi?
- Fundz holds 4 contacts at Sanofi. Names and contact details are shown to Fundz members.
Source: Fundz verified event record.
Other recent acquisitions in Medical and Pharmaceutical
Deals where the buyer or target shares a sector with this one, within 45 days, from Fundz verified event records.
- Gilead Sciences to acquire MacroGenics for $1.7B, $1.7B (May 19, 2026)
- Eli Lilly to acquire Ajax Therapeutics for $2.3B, $2.3B (April 27, 2026)
- Eli Lilly to acquire Centessa Pharmaceuticals (March 31, 2026)
- Aurinia acquires Kezar Life Sciences for $6.955/share (March 30, 2026)
- Selecta Biosciences merges with Cartesian Therapeutics (May 17, 2026)
- ESTEVE acquires TerSera's Infusion Business Unit (May 4, 2026)
Who to call at Sanofi, and when
When Sanofi changes hands, the new owners review vendors, systems and leadership. That is when the door opens.
- An alert the day Sanofi raises, hires an executive or expands, scored against what you sell
- The decision-makers there, with verified emails
- Who you already know at Sanofi, from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at Sanofi. With Fundz connected, it knows.
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment Sanofi makes an acquisition, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
Related People
Frequently asked
Who acquired Dynavax Technologies?
Dynavax Technologies was acquired by Sanofi. The deal was reported on April 23, 2026. Sanofi is publicly traded (SNY) and operates in Biotechnology.
When did Sanofi acquire Dynavax Technologies?
Sanofi's acquisition of Dynavax Technologies was reported on April 23, 2026. Sanofi has completed its acquisition of Dynavax Technologies. This acquisition is aimed at enhancing Sanofi's vaccine development and immunotherapy capabilities. Fundz records the date the transaction was first publicly reported, sourced from filings and company announcements.
What does Dynavax Technologies do?
Dynavax Technologies Corp. is a biopharmaceutical company that focuses on developing and commercializing novel vaccines. It is privately held, operating in Biotechnology, and is based in Emeryville.
This company was part of an acquisition. Fundz tracks who bought whom, and who to call on both sides.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.